BlackRock Fund Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

BlackRock Fund Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$867K	Buy	3,418 +103	+3%	+$23.6K	﹤0.01%	3235
2016 Q3	$675K	Buy	3,315 +516	+18%	+$64.2K	﹤0.01%	3254
2016 Q2	$251K	Buy	2,799 +1,087	+63%	+$85.2K	﹤0.01%	3380
2016 Q1	$93K	Sell	1,712 -114	-6%	-$5.03K	﹤0.01%	3681
2015 Q4	$90K	Buy	1,826 +126	+7%	+$6.42K	﹤0.01%	3755
2015 Q3	$80K	Sell	1,700 -45	-3%	-$3K	﹤0.01%	3744
2015 Q2	$161K	Buy	+1,745	New	+$175K	﹤0.01%	3612

Other funds holding CRBP

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BlackRock Fund Advisors's CRBP Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Corbus Pharmaceuticals (CRBP) stake by 3.1% in Q4 2016, buying an estimated $23.6K and bringing the position to 3,418 shares worth $867K. The position accounts for ﹤0.01% of the portfolio, ranked #3235.

BlackRock Fund Advisors first reported a position in CRBP in Q2 2015 and has held it in 7 quarters since. 49 funds tracked by Wall St. Rank hold CRBP as of Q4 2016.

BlackRock Fund Advisors held 3,418 shares of Corbus Pharmaceuticals worth $867K as of Q4 2016.
BlackRock Fund Advisors bought 103 Corbus Pharmaceuticals shares in Q4 2016, an estimated $23.6K.
Corbus Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3235 holding.
BlackRock Fund Advisors first reported a position in Corbus Pharmaceuticals in Q2 2015 and has held it in 7 quarters since.
49 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.